129 related articles for article (PubMed ID: 26648475)
41. Brain region-specific regulation of urocortin 1 innervation and corticotropin-releasing factor receptor type 2 binding by ethanol exposure.
Weitemier AZ; Ryabinin AE
Alcohol Clin Exp Res; 2005 Sep; 29(9):1610-20. PubMed ID: 16205361
[TBL] [Abstract][Full Text] [Related]
42. UVA-induced calcium oscillations in rat mast cells.
Zhou YD; Fang XF; Cui ZJ
Cell Calcium; 2009 Jan; 45(1):18-28. PubMed ID: 18602157
[TBL] [Abstract][Full Text] [Related]
43. Urocortin and the brain.
Pan W; Kastin AJ
Prog Neurobiol; 2008 Feb; 84(2):148-56. PubMed ID: 18078706
[TBL] [Abstract][Full Text] [Related]
44. Long-Term Ultraviolet A Eye Irradiation Causes Retina Denaturation in Mice.
Hiramoto K; Yamate Y; Sato EF
Biomed Hub; 2017; 2(1):1-10. PubMed ID: 31988904
[TBL] [Abstract][Full Text] [Related]
45. Expression and role of the corticotropin-releasing hormone/urocortin-receptor-binding protein system in the primate corpus luteum during the menstrual cycle.
Xu J; Xu F; Hennebold JD; Molskness TA; Stouffer RL
Endocrinology; 2007 Nov; 148(11):5385-95. PubMed ID: 17690168
[TBL] [Abstract][Full Text] [Related]
46. Ultraviolet B radiation to the eye induces pigmentation in the epidermis via the activation of the subunit gp91 phox of reduced nicotinamide adenine dinucleotide phosphate oxidase.
Hiramoto K; Sato EF
Clin Exp Dermatol; 2012 Jan; 37(1):65-7. PubMed ID: 21883395
[TBL] [Abstract][Full Text] [Related]
47. Role of gp91phox (Nox2)-containing NAD(P)H oxidase in angiogenesis in response to hindlimb ischemia.
Tojo T; Ushio-Fukai M; Yamaoka-Tojo M; Ikeda S; Patrushev N; Alexander RW
Circulation; 2005 May; 111(18):2347-55. PubMed ID: 15867174
[TBL] [Abstract][Full Text] [Related]
48. Glucocorticoids regulate the expression of the mouse urocortin II gene: a putative connection between the corticotropin-releasing factor receptor pathways.
Chen A; Vaughan J; Vale WW
Mol Endocrinol; 2003 Aug; 17(8):1622-39. PubMed ID: 12764078
[TBL] [Abstract][Full Text] [Related]
49. [Study on the level of placental urocortin and corticotropin-releasing hormone receptor 2beta of preeclampsia].
Cheng ZX; Shang T; Zhang L
Zhonghua Fu Chan Ke Za Zhi; 2005 Apr; 40(4):256-9. PubMed ID: 15924674
[TBL] [Abstract][Full Text] [Related]
50. Peroxiredoxin I plays a protective role against UVA irradiation through reduction of oxidative stress.
Ito T; Kimura S; Seto K; Warabi E; Kawachi Y; Shoda J; Tabuchi K; Yamagata K; Hasegawa S; Bukawa H; Ishii T; Yanagawa T
J Dermatol Sci; 2014 Apr; 74(1):9-17. PubMed ID: 24388414
[TBL] [Abstract][Full Text] [Related]
51. Corticotropin-releasing factor (CRF) and urocortin promote the survival of cultured cerebellar GABAergic neurons through the type 1 CRF receptor.
Choi JS; Pham TT; Jang YJ; Bui BC; Lee BH; Joo KM; Cha CI; Lee KH
J Korean Med Sci; 2006 Jun; 21(3):518-26. PubMed ID: 16778399
[TBL] [Abstract][Full Text] [Related]
52. Urocortin expression in the Edinger-Westphal nucleus is up-regulated by stress and corticotropin-releasing hormone deficiency.
Weninger SC; Peters LL; Majzoub JA
Endocrinology; 2000 Jan; 141(1):256-63. PubMed ID: 10614646
[TBL] [Abstract][Full Text] [Related]
53. Angiotensin II-dependent chronic hypertension and cardiac hypertrophy are unaffected by gp91phox-containing NADPH oxidase.
Touyz RM; Mercure C; He Y; Javeshghani D; Yao G; Callera GE; Yogi A; Lochard N; Reudelhuber TL
Hypertension; 2005 Apr; 45(4):530-7. PubMed ID: 15753233
[TBL] [Abstract][Full Text] [Related]
54. UVA irradiation of the eye modulates the contact hypersensitivity of the skin and intestines by affecting mast cells in mice.
Yamate Y; Hiramoto K; Kasahara E; Sato EF
Photodermatol Photoimmunol Photomed; 2015 May; 31(3):129-40. PubMed ID: 25495784
[TBL] [Abstract][Full Text] [Related]
55. Ultraviolet A sensitivity in Smith-Lemli-Opitz syndrome: Possible involvement of cholesta-5,7,9(11)-trien-3 beta-ol.
Chignell CF; Kukielczak BM; Sik RH; Bilski PJ; He YY
Free Radic Biol Med; 2006 Jul; 41(2):339-46. PubMed ID: 16814115
[TBL] [Abstract][Full Text] [Related]
56. Corticotropin-releasing hormone skin signaling is receptor-mediated and is predominant in the sebaceous glands.
Krause K; Schnitger A; Fimmel S; Glass E; Zouboulis CC
Horm Metab Res; 2007 Feb; 39(2):166-70. PubMed ID: 17326013
[TBL] [Abstract][Full Text] [Related]
57. Role of NADPH oxidase in the brain injury of intracerebral hemorrhage.
Tang J; Liu J; Zhou C; Ostanin D; Grisham MB; Neil Granger D; Zhang JH
J Neurochem; 2005 Sep; 94(5):1342-50. PubMed ID: 16011743
[TBL] [Abstract][Full Text] [Related]
58. Regulation of corticotropin-releasing factor and urocortin 2/3 mRNA by leptin in hypothalamic N39 cells.
Yamagata S; Kageyama K; Akimoto K; Watanuki Y; Suda T; Daimon M
Peptides; 2013 Dec; 50():1-7. PubMed ID: 24083959
[TBL] [Abstract][Full Text] [Related]
59. Corticotropin-releasing hormone induces skin mast cell degranulation and increased vascular permeability, a possible explanation for its proinflammatory effects.
Theoharides TC; Singh LK; Boucher W; Pang X; Letourneau R; Webster E; Chrousos G
Endocrinology; 1998 Jan; 139(1):403-13. PubMed ID: 9421440
[TBL] [Abstract][Full Text] [Related]
60. Involvement of the corticotropin-releasing factor (CRF) type 2 receptor in CRF-induced thyrotropin release by the amphibian pituitary gland.
Okada R; Miller MF; Yamamoto K; De Groef B; Denver RJ; Kikuyama S
Gen Comp Endocrinol; 2007 Feb; 150(3):437-44. PubMed ID: 17188689
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
